FDA backs Medtronic implantable neurostimulator with 11-year life | 2021-06-10 | BioWorld
Medtronic unveils positive data from Intellis SCS therapy trial in back pain
Spinal Cord Stimulation (SCS) – Sonna Medika Jaya
Utilizing a Double Epidural Electrical Stimulation Implant For SCI
The Intellis™ platform is designed to optimize pain treatment delivery. The Intellis™ SCS, with its cutting-edge features, and our Overdrive™ battery... | By Medtronic India | Facebook